688266 澤璟製藥
按盤價 
51.480 -0.830 (-1.587%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.448 | -23.293 | -46.775 | -32.053 | -39.380 |
| 總資產報酬率 ROA (%) | -1.318 | -12.231 | -26.789 | -24.272 | -27.874 |
| 投入資產回報率 ROIC (%) | -1.454 | -14.257 | -33.181 | -28.859 | -18.616 | 邊際利潤分析 |
| 銷售毛利率 (%) | 93.395 | 92.441 | 91.346 | 96.707 | 99.901 |
| 營業利潤率 (%) | -42.149 | -77.058 | -160.618 | -241.145 | -1,102.018 |
| 息稅前利潤/營業總收入 (%) | -48.580 | -81.244 | -165.924 | -262.516 | -1,250.446 |
| 淨利潤/營業總收入 (%) | -41.231 | -76.373 | -160.601 | -242.693 | -1,123.157 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 111.115 | 131.168 | 107.252 | 109.426 | 111.604 |
| 價值變動淨收益/利潤總額(%) | -6.549 | -4.910 | -1.349 | -2.752 | -4.028 |
| 營業外收支淨額/利潤總額(%) | -0.001 | 0.435 | 0.491 | 1.312 | 0.002 | 償債能力分析 |
| 流動比率 (X) | 2.254 | 2.220 | 1.772 | 3.691 | 11.851 |
| 速動比率 (X) | 2.146 | 2.123 | 1.636 | 3.555 | 11.687 |
| 資產負債率 (%) | 48.443 | 43.030 | 52.797 | 28.230 | 14.145 |
| 帶息債務/全部投入資本 (%) | 33.617 | 32.749 | 34.824 | 8.893 | -- |
| 股東權益/帶息債務 (%) | 166.552 | 192.701 | 165.078 | 936.788 | -4,499.415 |
| 股東權益/負債合計 (%) | 105.961 | 131.430 | 86.183 | 242.721 | 580.470 |
| 利息保障倍數 (X) | 7.554 | 21.108 | 36.770 | 14.452 | 8.426 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 88.617 | 88.559 | 90.121 | 117.952 | 0.000 |
| 存貨周轉天數 (天) | 1,518.731 | 1,292.941 | 1,038.189 | 2,154.996 | 0.000 |
| 備註： | 即時報價更新時間為 03/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
